Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gw 780604
2. Gw 786034b
3. Gw-780604
4. Gw-786034b
5. Gw780604
6. Gw786034b
7. Pazopanib
8. Votrient
1. 635702-64-6
2. Pazopanib Hcl
3. Votrient
4. Pazopanib (hydrochloride)
5. Armala
6. Unii-33y9anm545
7. Pazopanib Monohydrochloride
8. Pazopanib Hcl (gw786034 Hcl)
9. Gw786034b
10. Gw-786034b
11. Pazopanib (as Hydrochloride)
12. Gw786034 (hydrochloride)
13. 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
14. Chebi:71217
15. 33y9anm545
16. S1035
17. 5-((4-((2,3-dimethyl-2h-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide Hydrochloride
18. 5-((4-((2,3-dimethyl-2h-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide Monohydrochloride
19. 5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide Hydrochloride
20. 5-{4-[(2,3-dimethyl-2h-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide Hydrochloride
21. Benzenesulfonamide, 5-((4-((2,3-dimethyl-2h-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, Monohydrochloride
22. Patorma
23. Gw786034 Hcl
24. Votrient Hcl
25. Votrient (tn)
26. 5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide Hydrochloride
27. Pazopanib Hydrochloride [usan:jan]
28. Mls004774147
29. Schembl159487
30. Pazopanib Hydrochloride- Bio-x
31. Pazopanib Hydrochloride [usan]
32. Chembl1201733
33. Dtxsid70212956
34. Ex-a956
35. Pazopanib Hcl (gw786034 )
36. Bcp02203
37. Pazopanib Hydrochloride (jan/usan)
38. Pazopanib Hydrochloride [mi]
39. Mfcd12546138
40. Nsc737754
41. Pazopanib Hydrochloride [jan]
42. Akos015958593
43. Bcp9001052
44. Ccg-269485
45. Cs-0126
46. Gsk-786034
47. Ks-1458
48. Nsc-737754
49. Pazopanib Hydrochloride [mart.]
50. Pb31655
51. Sb10367
52. Pazopanib Hydrochloride [who-dd]
53. Ac-24726
54. Bp166746
55. Hy-12009
56. Smr003500790
57. Am20090655
58. Ft-0687642
59. P2243
60. Pazopanib Hydrochloride [orange Book]
61. Sw218082-2
62. Ec-000.2347
63. D05380
64. A834417
65. Q27888072
66. 5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide Hydrochloride
67. 5-(4-((2,3-dimethyl-2h-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide Hydrochloride
68. 5-(4-((2,3-dimethyl-2h-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide Hydrochloride;5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide Hydrochloride
69. 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide Hydrochloride
70. Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, Hydrochloride (1:1)
Molecular Weight | 474.0 g/mol |
---|---|
Molecular Formula | C21H24ClN7O2S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 473.1400719 g/mol |
Monoisotopic Mass | 473.1400719 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 717 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Votrient |
PubMed Health | Pazopanib (By mouth) |
Drug Classes | Antineoplastic Agent, Immunological Agent |
Active Ingredient | Pazopanib hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 200mg base; eq 400mg base |
Market Status | Prescription |
Company | Glaxosmithkline |
2 of 2 | |
---|---|
Drug Name | Votrient |
PubMed Health | Pazopanib (By mouth) |
Drug Classes | Antineoplastic Agent, Immunological Agent |
Active Ingredient | Pazopanib hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 200mg base; eq 400mg base |
Market Status | Prescription |
Company | Glaxosmithkline |
* Renal-cell carcinoma (RCC):
Votrient is indicated in adults for the first-line treatment of advanced renal-cell carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.
* Soft-tissue sarcoma (STS):
Votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft-tissue sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo)adjuvant therapy.
Efficacy and safety have only been established in certain STS histological tumour subtypes.
L01XE11
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35732
Submission : 2021-03-31
Status : Active
Type : II
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-29
Pay. Date : 2021-10-04
DMF Number : 36192
Submission : 2021-10-04
Status : Active
Type : II
NDC Package Code : 16436-0125
Start Marketing Date : 2020-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36037
Submission : 2021-06-30
Status : Active
Type : II
NDC Package Code : 62207-977
Start Marketing Date : 2021-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-10-07
Pay. Date : 2021-07-30
DMF Number : 33054
Submission : 2018-07-28
Status : Active
Type : II
Date of Issue : 2024-11-28
Valid Till : 2024-07-15
Written Confirmation Number : WC-0327n
Address of the Firm :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35732
Submission : 2021-03-31
Status : Active
Type : II
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-29
Pay. Date : 2021-10-04
DMF Number : 36192
Submission : 2021-10-04
Status : Active
Type : II
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36037
Submission : 2021-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-10-07
Pay. Date : 2021-07-30
DMF Number : 33054
Submission : 2018-07-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32899
Submission : 2018-07-05
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-10
Pay. Date : 2017-01-10
DMF Number : 31297
Submission : 2017-01-03
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-17
Pay. Date : 2013-05-17
DMF Number : 26207
Submission : 2012-07-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34693
Submission : 2020-03-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35813
Submission : 2021-04-14
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-04-09
Pay. Date : 2018-03-07
DMF Number : 27422
Submission : 2013-08-31
Status : Active
Type : II
Date of Issue : 2019-01-14
Valid Till : 2021-07-15
Written Confirmation Number : WC-0327
Address of the Firm : No.116/117 KIADB Industial area, Jigani, Bangalore-560105 Karnataka
Date of Issue : 2024-11-28
Valid Till : 2024-07-15
Written Confirmation Number : WC-0327n
Address of the Firm : Plot No 116/117, KIADB Industrial Area, Jigani, Bangalore,Karnataka, India
Date of Issue : 2022-11-09
Valid Till : 2025-08-08
Written Confirmation Number : WC-0138
Address of the Firm : Plot No. 285, 286 & 287, Bommasandra-Jigani Link Road, Industrial Area, KIADB, 4...
Date of Issue : 2021-07-09
Valid Till : 2022-08-08
Written Confirmation Number : WC-0138A3
Address of the Firm : Plot No. 285, 286 & 287, Bommasandra-Jigani Link Road, Industrial Area, KIADB, 4...
Date of Issue : 2022-09-16
Valid Till : 2025-08-08
Written Confirmation Number : WC-0041
Address of the Firm : Unit-I, Survey No.10, I.D.A, Gaddapotharam Village, Jinnaram Mandal,Medak Dist, ...
Pazopanib Hydrochloride In house
Date of Issue : 2023-07-03
Valid Till : 2025-07-02
Written Confirmation Number : WC-0213
Address of the Firm : Plot No.21, Jawaharlal Nehru Pharma City, Parawada MandaI, Visakhapatnam, Visakh...
Date of Issue : 2022-09-02
Valid Till : 2025-05-05
Written Confirmation Number : WC-0349
Address of the Firm : MIs. MSN Laboratories Private Limited, Unit-II, sv. No, 50, Kardanur (Village), ...
Registrant Name : Novartis Korea Ltd.
Registration Date : 2023-07-12
Registration Number : 196-26-ND
Manufacturer Name : FIS Fabbrica Italiana Sintet...
Manufacturer Address : Viale Milano, 26, 36075 Montecchio Maggiore (Vicenza), Italy@Crossways Boulevard, Cro...
Registrant Name : M-Peak Korea Co., Ltd.
Registration Date : 2020-10-21
Registration Number : Number 812-12-ND
Manufacturer Name : Formosa Laboratories, Inc.
Manufacturer Address : 36 Hoping Street, Louchu, Taoyuan 33842, Taiwan
Registrant Name : Novartis Korea Ltd.
Registration Date : 2012-07-31
Registration Number : 89-11-ND
Manufacturer Name : Glaxo Wellcome Manufacturing...
Manufacturer Address : 1 Pioneer Sector 1, Jurong, Singapore 628413@[Undifferentiated Manufacturer] Crossway...
Registrant Name : Klasia Co., Ltd.
Registration Date : 2021-10-25
Registration Number : No. 758-8-ND
Manufacturer Name : Kekule Pharma Limited
Manufacturer Address : MIA, Kazipally, Jinnaram Mandal, Sangareddy-502 319, Telangana State, India
Registrant Name : Novartis Korea Ltd.
Registration Date : 2021-03-23
Registration Number : 196-22-ND
Manufacturer Name : Thermo Fisher Scientific Cor...
Manufacturer Address : Currabinny, Carrigaline, County Cork, P43 AY66, Ireland@Crossways Boulevard, Crossway...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
About the Company : Medichem is an indepently-owned company based in Barcelona. Founded in 1972 and with more than 45 years, Medichem has been engaged in the process development and manufacture of Act...
About the Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
About the Company : Granules is a vertically integrated fast-growing Pharmaceutical company headquartered in Hyderabad with best-in-class facilities & a commitment to operational excellence, quality, ...
About the Company : Parsian Pharmaceutical is dedicated to improving health outcomes by offering high-quality, effective pharmaceutical products. With a strong commitment to research, innovation, and ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
Details:
Votrient-Generic (pazopanib HCl) is a multi-kinase inhibitor, which is indicated for the treatment of adults with advanced renal cell carcinoma & advanced soft tissue sarcoma.
Lead Product(s): Pazopanib Hydrochloride
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 05, 2024
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Eugia Pharma Receives USFDA Approval for Pazopanib Tablets, 200 mg
Details : Votrient-Generic (pazopanib HCl) is a multi-kinase inhibitor, which is indicated for the treatment of adults with advanced renal cell carcinoma & advanced soft tissue sarcoma.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Not Applicable
December 05, 2024
Details:
Vorient-Generic (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma & advanced soft tissue sarcoma who have received prior chemotherapy.
Lead Product(s): Pazopanib Hydrochloride
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 05, 2024
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Auro Pharma Arm Gets USFDA Nod for Pazopanib Tablet
Details : Vorient-Generic (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma & advanced soft tissue sarcoma who have received prior chemotherapy.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Not Applicable
December 05, 2024
Details:
Vorient-Generic (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma & advanced soft tissue sarcoma who have received prior chemotherapy.
Lead Product(s): Pazopanib Hydrochloride
Therapeutic Area: Oncology Brand Name: Vorient-Generic
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Midas Pharma
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 26, 2021
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Midas Pharma
Deal Size : Not Applicable
Deal Type : Not Applicable
Midas Pharma’s Partner, the Malta-based Generics Developer Pharmacare Premium, Has Successfully ...
Details : Vorient-Generic (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma & advanced soft tissue sarcoma who have received prior chemotherapy.
Product Name : Vorient-Generic
Product Type : Small molecule
Upfront Cash : Not Applicable
August 26, 2021
CAS Number : 20191-74-6
End Use API : Pazopanib Hydrochloride
About The Company : Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it has a broad international reach. With over a century of...
5-AMINO-2-METHYLBENZENESULFONAMIDE
CAS Number : 6973-09-7
End Use API : Pazopanib Hydrochloride
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
CAS Number : 3934-20-1
End Use API : Pazopanib Hydrochloride
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2...
CAS Number : 444731-75-3
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2...
CAS Number : 444731-74-2
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
2,3-dimethyl-2H-indazol-6-amine hydrochloride
CAS Number : 635702-60-2
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
2,3-dimethyl-2H-indazol-6-amine
CAS Number : 444731-72-0
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
2,3-dimethyl-6-Nitro-2H-indazole
CAS Number : 444731-73-1
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
CAS Number : 6494-19-5
End Use API : Pazopanib Hydrochloride
About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...
2,3-Dimethyl-2H-indazol-6-amine hydrochloride
CAS Number : 635702-60-2
End Use API : Pazopanib Hydrochloride
About The Company : Founded in 1986, Kekule has developed from a manufacturer of few molecules to a preferred vendor for many complex molecules requiring multistage synthesis. Work...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
69
PharmaCompass offers a list of Pazopanib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pazopanib Hydrochloride manufacturer or Pazopanib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pazopanib Hydrochloride manufacturer or Pazopanib Hydrochloride supplier.
PharmaCompass also assists you with knowing the Pazopanib Hydrochloride API Price utilized in the formulation of products. Pazopanib Hydrochloride API Price is not always fixed or binding as the Pazopanib Hydrochloride Price is obtained through a variety of data sources. The Pazopanib Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pazopanib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pazopanib Hydrochloride, including repackagers and relabelers. The FDA regulates Pazopanib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pazopanib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pazopanib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pazopanib Hydrochloride supplier is an individual or a company that provides Pazopanib Hydrochloride active pharmaceutical ingredient (API) or Pazopanib Hydrochloride finished formulations upon request. The Pazopanib Hydrochloride suppliers may include Pazopanib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Pazopanib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pazopanib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Pazopanib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Pazopanib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Pazopanib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pazopanib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Pazopanib Hydrochloride USDMF includes data on Pazopanib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pazopanib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pazopanib Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pazopanib Hydrochloride Drug Master File in Korea (Pazopanib Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pazopanib Hydrochloride. The MFDS reviews the Pazopanib Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Pazopanib Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pazopanib Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pazopanib Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pazopanib Hydrochloride suppliers with KDMF on PharmaCompass.
A Pazopanib Hydrochloride written confirmation (Pazopanib Hydrochloride WC) is an official document issued by a regulatory agency to a Pazopanib Hydrochloride manufacturer, verifying that the manufacturing facility of a Pazopanib Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pazopanib Hydrochloride APIs or Pazopanib Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Pazopanib Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Pazopanib Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pazopanib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pazopanib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pazopanib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pazopanib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pazopanib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pazopanib Hydrochloride suppliers with NDC on PharmaCompass.
Pazopanib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pazopanib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pazopanib Hydrochloride GMP manufacturer or Pazopanib Hydrochloride GMP API supplier for your needs.
A Pazopanib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Pazopanib Hydrochloride's compliance with Pazopanib Hydrochloride specifications and serves as a tool for batch-level quality control.
Pazopanib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Pazopanib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pazopanib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Pazopanib Hydrochloride EP), Pazopanib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pazopanib Hydrochloride USP).